Skip to main content

Advertisement

SpringerLink
Log in

ERCC polymorphisms and prognosis of patients with osteosarcoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Osteosarcoma is the most common primary bone malignancy in children and teenagers, and its clinical outcome remains poor. Previous studies have investigated the association between excision repair cross-complementing (ERCC) and prognosis of osteosarcoma patients, but their results were inconsistent. We aimed to clarify the associations between ERCC polymorphisms and osteosarcoma prognosis by using meta-analysis. We searched relevant studies in PubMed, Embase, coupled with Chinese National Knowledge Infrastructure (CNKI) in human osteosarcoma published prior to April, 2014. Hazard ratios (HR) together with their 95 % confidence intervals (95 % CI) were used to measure the relationship between ERCC mutations and prognosis in patients with osteosarcoma. Pooled results showed that polymorphism of ERCC2 Lys751Gln was associated with the overall survival of osteosarcoma (GG vs. AA, HR = 0.40; 95 % CI 0.18–0.86), and ERCC5 His46His mutation was associated with the event-free survival of osteosarcoma (CC vs. TT, HR = 0.37; 95 % CI 0.15, 0.93). In addition, there is no evidence of association on ERCC1 Asn118Asn, ERCC1 Gln504Lys, and ERCC2 Asp312Asn polymorphisms with prognosis in osteosarcoma. In summary, the ERCC2 Lys751Gln and ERCC5 His46His polymorphisms might influence osteosarcoma prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M. Emerging drugs for high-grade osteosarcoma. Expert Opin Drug Saf. 2010;15:615–34.

    CAS  Google Scholar 

  2. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9:422–41.

    Article  PubMed  Google Scholar 

  3. Fletcher CD, Unni KK, Mertens F: Pathology and genetics of tumours of soft tissue and bone. Iarc, 2002.

  4. Bai SB, Chen HX, Bao YX, Luo X, Zhong JJ. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma. Asian Pacific journal of cancer prevention : APJCP. 2013;14:3677–80.

    Article  PubMed  Google Scholar 

  5. Chou AJ, Gorlick R. Chemotherapy resistance in osteosarcoma: Current challenges and future directions. Expert Rev Anticancer Ther. 2006;6:1075–85.

    Article  CAS  PubMed  Google Scholar 

  6. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006;32:423–36.

    Article  PubMed  Google Scholar 

  7. Sun XH, Hou WG, Zhao HX, Zhao YL, Ma C, Liu Y. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors. Asian Pacific journal of cancer prevention: APJCP. 2013;14:2049–52.

    Article  PubMed  Google Scholar 

  8. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2002;11:1513–30.

    CAS  Google Scholar 

  9. Jones AR, Bell-Horwath TR, Li G, Rollmann SM, Merino EJ. Novel oxidatively activated agents modify DNA and are enhanced by ERCC1 silencing. Chem Res Toxicol. 2012;25:2542–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shannon M, Lamerdin JE, Richardson L, McCutchen-Maloney SL, Hwang MH, Handel MA, et al. Characterization of the mouse xpf DNA repair gene and differential expression during spermatogenesis. Genomics. 1999;62:427–35.

    Article  CAS  PubMed  Google Scholar 

  11. Lu B, Li J, Gao Q, Yu W, Yang Q, Li X. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ercc1, ercc2, ercc3, ercc4, ercc5 and xpa. Gene. 2014;542:64–8.

    Article  CAS  PubMed  Google Scholar 

  12. Wu Y, Yang Y: Complex association between ercc2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: A meta-analysis. Tumor Biology 2014;35:1–13.

  13. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

    Article  PubMed  Google Scholar 

  14. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

  15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557.

    Article  Google Scholar 

  16. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity BMJ. Br Med J. 1998;316:469.

    Article  CAS  Google Scholar 

  18. Yang L-M, Li X-H, Bao C-F. Glutathione s-transferase p1 and DNA polymorphisms with the response to chemotherapy and the prognosis of bone tumor. Asian Pacific Journal of Cancer Prevention. 2012;13:5883–6.

    Article  PubMed  Google Scholar 

  19. Hao T, Feng W, Zhang J, Sun Y-J, Wang G. Association of four ercc1 and ercc2 SNPS with survival of bone tumour patients. Asian Pacific journal of cancer prevention : APJCP. 2012;13:3821–4.

    Article  PubMed  Google Scholar 

  20. Caronia D, Patino-Garcia A, Milne RL, Zalacain-Diez M, Pita G, Alonso MR, et al. Common variations in ercc2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics. 2009;9:347–53.

    Article  CAS  Google Scholar 

  21. Biason P, Hattinger C, Innocenti F, Talamini R, Alberghini M, Scotlandi K, et al. Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy. The pharmacogenomics journal. 2012;12:476–83.

    Article  CAS  PubMed  Google Scholar 

  22. Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008;134:281–97.

    Article  CAS  PubMed  Google Scholar 

  23. Caronia D, Patino-Garcia A, Milne R, Zalacain-Diez M, Pita G, Alonso M, et al. Common variations in ercc2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. The pharmacogenomics journal. 2009;9:347–53.

    Article  CAS  PubMed  Google Scholar 

  24. Friedberg EC, Walker GC, Siede W: DNA repair and mutagenesis. American Society for Microbiology (ASM), 1995.

  25. Aiub CAF, Mazzei JL, Pinto LFR, Felzenszwalb I. Participation of BER and NER pathways in the repair of DNA lesions induced at low < i > n</i > −nitrosodiethylamine concentrations. Toxicol Lett. 2004;154:133–42.

    Article  CAS  PubMed  Google Scholar 

  26. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411:366–74.

    Article  CAS  PubMed  Google Scholar 

  27. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL. Sanford KK Bell DA: Xpd polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–5.

    Article  CAS  PubMed  Google Scholar 

  28. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, Grossman L, Mohrenweiser H, Wei Q: Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic xpc and xpd/ercc2 genotypes. carcinogenesis 2002;23:295–299.

  29. Au WW, Salama SA. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect. 2003;111:1843.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomark Prev. 2003;12:674–7.

    CAS  Google Scholar 

  31. Xin Y, Hao S, Lu J, Wang Q, Zhang L. Association of ercc1 c8092a and ercc2 lys751gln polymorphisms with the risk of glioma: a meta-analysis. PLoS One. 2014;9:e95966.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ni M, Zhang W-z, Qiu J-r, Liu F, Li M, Zhang Y-j, Liu Q, Bai J: Association of ercc1 and ercc2 polymorphisms with colorectal cancer risk in a Chinese population. Scientific reports 2014; 4

  33. Uemura S, Kuramochi H, Higuchi R, Nakajima G, Yamamoto M: Ercc1 mRNA expression as a postoperative prognostic marker in extrahepatic bile duct cancer. Annals of surgical oncology 2014:1–7.

  34. Koeppel F, Poindessous V, Lazar V, Raymond E, Sarasin A, Larsen AK. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with xpg expression in solid tumor cells. Clin Cancer Res. 2004;10:5604–13.

    Article  CAS  PubMed  Google Scholar 

  35. Zhao YL, Yang LB, Geng XL, Zhou QL, Qin H, Yang L, et al. The association of xpg and mms19l polymorphisms response to chemotherapy in osteosarcoma. Pakistan journal of medical sciences. 2013;29:1225–9.

    PubMed  PubMed Central  Google Scholar 

  36. Hatfield MD, Reis AM, Obeso D, Cook JR, Thompson DM, Rao M, et al. Identification of mms19 domains with distinct functions in NER and transcription. DNA Repair (Amst). 2006;5:914–24.

    Article  CAS  Google Scholar 

  37. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53:207–16.

    Article  CAS  PubMed  Google Scholar 

  38. Poynard T, Conn HO. The retrieval of randomized clinical trials in liver disease from the medical literature: a comparison of medlars and manual methods. Control Clin Trials. 1985;6:271–9.

    Article  CAS  PubMed  Google Scholar 

  39. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.

    Article  PubMed  Google Scholar 

Download references

Conflict of interests

None

Author information

Authors and Affiliations

  1. Department of Orthopaedics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

    Jinsong Li, Weiguo Wang, Kexiang Zhang, Zhendong Liu, Chaoyue Zhang, Shijie Chen & Song Wu

  2. Department of Spine Surgery, The Xiangya Hospital of Central South University, Changsha, Hunan, China

    Shaohua Liu

Authors
  1. Jinsong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaohua Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weiguo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kexiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhendong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chaoyue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shijie Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Song Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Shijie Chen or Song Wu.

Additional information

Jinsong Li and Shaohua Liu contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Liu, S., Wang, W. et al. ERCC polymorphisms and prognosis of patients with osteosarcoma. Tumor Biol. 35, 10129–10136 (2014). https://doi.org/10.1007/s13277-014-2322-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2322-1

Keywords

Search

Navigation